Site-specific N- and O-glycosylation analysis of atacicept

References

• Kaplon H, Reichert JM. Antibodies to watch in 2019. MAbs. 2019;11:219–38. doi:10.1080/19420862.2018.1556465.
   PubMed Web of Science ®Google Scholar
• Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nat Biotechnol. 2014;32:40–51. doi:10.1038/nbt.2786.
   PubMed Web of Science ®Google Scholar
• Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, Xu W, Parrish-Novak J, Foster D, Lofton-Day C, et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 2000;404:995–99. doi:10.1038/35010115.
   PubMed Web of Science ®Google Scholar
• Hartung H-P, Kieseier BC. Atacicept: targeting B cells in multiple sclerosis. Ther Adv Neurol Disord. 2010;3:205–16. doi:10.1177/1756285610371146.
   PubMedGoogle Scholar
• Suzuki T, Ishii-Watabe A, Tada M, Kobayashi T, Kanayasu-Toyoda T, Kawanishi T, Yamaguchi T. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR. J Immunol. 2010;184:1968–76. doi:10.4049/jimmunol.0903296.
   PubMed Web of Science ®Google Scholar
• Shukla AA, Hubbard B, Tressel T, Guhan S, Low D. Downstream processing of monoclonal antibodies-Application of platform approaches. J Chromatogr B Anal Technol Biomed Life Sci. 2007;848:28–39. doi:10.1016/j.jchromb.2006.09.026.
   PubMed Web of Science ®Google Scholar
• Liu L. Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins. J Pharm Sci. 2015;104:1866–84. doi:10.1002/jps.24444.
   PubMed Web of Science ®Google Scholar
• Carter PJ. Introduction to current and future protein therapeutics: A protein engineering perspective. Exp Cell Res. 2011;317:1261–69. doi:10.1016/j.yexcr.2011.02.013.
   PubMed Web of Science ®Google Scholar
• Zheng K, Bantog C, Bayer R. The impact of glycosylation on monoclonal antibody conformation and stability. MAbs. 2011;3:37–41. doi:10.4161/mabs.3.6.17922.
   Web of Science ®Google Scholar
• Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol. 2007;25:21–50. doi:10.1146/annurev.immunol.25.022106.141702.
   PubMed Web of Science ®Google Scholar
• Raju TS. Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Curr Opin Immunol. 2008;20:471–78. doi:10.1016/j.coi.2008.06.007.
   PubMed Web of Science ®Google Scholar
• Hossler P, Khattak SF, Li ZJ. Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology. 2009;19:936–49. doi:10.1093/glycob/cwp079.
   PubMed Web of Science ®Google Scholar
• WHO. Guidelines on the quality, safety and efficacy of biotherapeutic protein products prepared by recombinant DNA technology. No 987, Annex 4; Switzerland: WHO Press; 2013.
   Google Scholar
• Zhang L, Luo S, Zhang B. Glycan analysis of therapeutic glycoproteins. MAbs. 2016;8:205–15. doi:10.1080/19420862.2015.1117719.
   PubMed Web of Science ®Google Scholar
• Higgins E. Carbohydrate analysis throughout the development of a protein therapeutic. Glycoconj J. 2010;27:211–25. doi:10.1007/s10719-009-9261-x.
   PubMed Web of Science ®Google Scholar
• Thaysen-Andersen M, Packer NH. Advances in LC-MS/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the N- and O-glycoproteomes. Biochim Biophys Acta. 2014;1844:1437–52. doi:10.1016/j.bbapap.2014.05.002.
   PubMed Web of Science ®Google Scholar
• Parker BL, Thaysen-Andersen M, Solis N, Scott NE, Larsen MR, Graham ME, Packer NH, Cordwell SJ. Site-specific glycan-peptide analysis for determination of N-glycoproteome heterogeneity. J Proteome Res. 2013;12:5791–800. doi:10.1021/pr400783j.
   PubMed Web of Science ®Google Scholar
• Stavenhagen K, Kayili HM, Holst S, Koeleman C, Engel R, Wouters D, Zeerleder S, Salih B, Wuhrer M. N- and O-glycosylation analysis of human C1-inhibitor reveals extensive mucin-type O-glycosylation. Mol Cell Proteomics. 2017;17:1225–38. doi:10.1074/mcp.RA117.000240.
   PubMed Web of Science ®Google Scholar
• Čaval T, Tian W, Yang Z, Clausen H, Heck AJR. Direct quality control of glycoengineered erythropoietin variants. Nat Commun. 2018. doi:10.1038/s41467-018-05536-3.
   PubMed Web of Science ®Google Scholar
• Wohlschlager T, Scheffler K, Forstenlehner IC, Skala W, Senn S, Damoc E, Holzmann J, Huber CG. Native mass spectrometry combined with enzymatic dissection unravels glycoform heterogeneity of biopharmaceuticals. Nat Commun. 2018;9:1–9. doi:10.1038/s41467-018-04061-7.
   PubMed Web of Science ®Google Scholar
• Reusch D, Haberger M, Falck D, Peter B, Maier B, Gassner J, Hook M, Wagner K, Bonnington L, Bulau P, et al. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-part 2: mass spectrometric methods. MAbs. 2015;7:732–42. doi:10.1080/19420862.2015.1045173.
   PubMed Web of Science ®Google Scholar
• Stavenhagen K, Plomp R, Wuhrer M. Site-specific protein N- and O-glycosylation analysis by a C18-porous graphitized carbon-liquid chromatography-electrospray ionization mass spectrometry approach using Pronase treated glycopeptides. Anal Chem. 2015;87:11691–99. doi:10.1021/acs.analchem.5b02366.
   PubMed Web of Science ®Google Scholar
• Hinneburg H, Stavenhagen K, Schweiger-Hufnagel U, Pengelley S, Jabs W, Seeberger PH, Silva DV, Wuhrer M, Kolarich D. The art of destruction: optimizing collision energies in quadrupole-time of flight (Q-TOF) Instruments for glycopeptide-based glycoproteomics. J Am Soc Mass Spectrom. 2016;27:507–19. doi:10.1007/s13361-015-1308-6.
   PubMed Web of Science ®Google Scholar
• Plomp R, Dekkers G, Rombouts Y, Visser R, Koeleman CAM, Kammeijer GSM, Jansen BC, Rispens T, Hensbergen PJ, Vidarsson G, et al. Hinge-region O-glycosylation of human immunoglobulin G3 (IgG3). Mol Cell Proteomics. 2015;14:1373–84. doi:10.1074/mcp.M114.047381.
   PubMed Web of Science ®Google Scholar
• Stavenhagen K, Hinneburg H, Thaysen-Andersen M, Hartmann L, Silva DV, Fuchser J, Kaspar S, Rapp E, Seeberger PH, Kolarich D. Quantitative mapping of glycoprotein micro-heterogeneity and macro-heterogeneity: an evaluation of mass spectrometry signal strengths using synthetic peptides and glycopeptides. J Mass Spectrom. 2013;48:627–39. doi:10.1002/jms.3210.
   PubMed Web of Science ®Google Scholar
• Reiding KR, Blank D, Kuijper DM, Deelder AM, Wuhrer M. High-throughput profiling of protein N-glycosylation by MALDI-TOF-MS employing linkage-specific sialic acid esterification. Anal Chem. 2014;86:5784–93. doi:10.1021/ac500335t.
   PubMed Web of Science ®Google Scholar
• Jansen BC, Reiding KR, Bondt A, Hipgrave Ederveen AL, Palmblad M, Falck D, Wuhrer M. MassyTools: a high-throughput targeted data processing tool for relative quantitation and quality control developed for glycomic and glycoproteomic MALDI-MS. J Proteome Res. 2015;14:5088–98. doi:10.1021/acs.jproteome.5b00658.
   PubMed Web of Science ®Google Scholar
• Houel S, Hilliard M, Yu YQ, McLoughlin N, Martin SM, Rudd PM, Williams JP, Chen W. N- and O-glycosylation analysis of etanercept using liquid chromatography and quadrupole time-of-flight mass spectrometry equipped with electron-transfer dissociation functionality. Anal Chem. 2014;86:576–84. doi:10.1021/ac402726h.
   PubMed Web of Science ®Google Scholar
• Montacir O, Montacir H, Springer A, Hinderlich S, Mahboudi F, Saadati A, Parr MK. Physicochemical characterization, glycosylation pattern and biosimilarity assessment of the fusion protein etanercept. Protein J. 2018;37:164–79. doi:10.1007/s10930-018-9757-y.
   PubMed Web of Science ®Google Scholar
• Zhu L, Guo Q, Guo H, Liu T, Zheng Y, Gu P, Chen X, Wang H, Hou S, Guo Y. Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry. MAbs. 2014;6:1474–85. doi:10.4161/mabs.36313.
   PubMed Web of Science ®Google Scholar
• Edelman GM, Cunningham BA, Gall WE, Gottlieb PD, Rutishauser U, Waxdal MJ. The covalent structure of an entire gammaG immunoglobulin molecule. Proc Natl Acad Sci U S A. 1969;63:78–85. doi:10.1073/pnas.63.1.78.
   PubMed Web of Science ®Google Scholar
• Kolarich D, Windwarder M, Alagesan K, Altmann F. Isomer-specific analysis of released n-glycans by lc-esi ms/ms with porous graphitized carbon. In: Castilho A, editor. Methods Mol. Biol. New York, NY: Springer Science+Business Media; 2015. p. 427–35.
   Google Scholar
• Pabst M, Bondili JS, Stadlmann J, Mach L, Altmann F. Mass + retention time = structure: a strategy for the analysis of N-glycans by carbon LC-ESI-MS and its application to fibrin N-glycans. Anal Chem. 2007;79:5051–57. doi:10.1021/ac070363i.
   PubMed Web of Science ®Google Scholar
• Everest-Dass AV, Jin D, Thaysen-Andersen M, Nevalainen H, Kolarich D, Packer N. Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans. Glycobiology. 2012;22:1465–79. doi:10.1093/glycob/cws112.
   PubMed Web of Science ®Google Scholar
• Issa SMA, Moran AP, Ustinov SN, Lin J-H-H, Ligtenberg AJ, Karlsson NG. O-linked oligosaccharides from salivary agglutinin: helicobacter pylori binding sialyl-Lewis x and Lewis b are terminating moieties on hyperfucosylated oligo-N-acetyllactosamine. Glycobiology. 2010;20:1046–57. doi:10.1093/glycob/cwq066.
   PubMed Web of Science ®Google Scholar
• Takeuchisq M, Miyazakis H, Katos T, Hoshis S, Kochibel N. Comparative study of the asparagine-linked sugar chains of human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells. J Biol Chem. 1988;263:3657–63.
   PubMed Web of Science ®Google Scholar
• Neumann S, Böcker S. Computational mass spectrometry for metabolomics: identification of metabolites and small molecules. Anal Bioanal Chem. 2010;398:2779–88. doi:10.1007/s00216-010-4142-5.
   PubMed Web of Science ®Google Scholar
• Lam H, Aebersold R. Building and searching tandem mass (MS/MS) spectral libraries for peptide identification in proteomics. Methods. 2011;54:424–31. doi:10.1016/j.ymeth.2011.01.007.
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen J, Sethi A, Li QK, Chen L, Collins B, Gillet LC, Wollscheid B, Zhang H, Aebersold R. Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness. Mol Cell Proteomics. 2014;13:1753–68. doi:10.1074/mcp.M114.038273.
   PubMed Web of Science ®Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–85. doi:10.1038/227680a0.
   PubMed Web of Science ®Google Scholar
• Stavenhagen K, Hinneburg H, Kolarich D, Wuhrer M. Site-specific N- and O-glycopeptide analysis using an integrated C18-PGC-LC-ESI-QTOF-MS-MS approach. In: Lauc G, Wuhrer M, editors. High-throughput glycomics glycoproteomics methods protoc. New York: Springer New York; 2017. p. 109–19.
   Google Scholar
• Jansen BC, Falck D, de Haan N, Hipgrave Ederveen AL, Razdorov G, Lauc G, Wuhrer M. LaCyTools – a targeted LC-MS data processing package for relative quantitation of glycopeptides. J Proteome Res. 2016;15:2198–210. doi:10.1021/acs.jproteome.6b00171.
   PubMed Web of Science ®Google Scholar
• Selman MHJ, Hemayatkar M, Deelder AM, Wuhrer M. Cotton HILIC SPE microtips for microscale purification and enrichment of glycans and glycopeptides. Anal Chem. 2011;83:2492–99. doi:10.1021/ac1027116.
   PubMed Web of Science ®Google Scholar
• Santos MR, Ratnayake CK, Fonslow B, Guttman A. A covalent, cationic polymer coating method for the CESI-MS analysis of intact proteins and polypeptides. Sciex - Bomarkers Omi. 2015; RUO-MKT-18-2325-A.
   Google Scholar